Experienced in Juvenile Idiopathic Arthritis (JIA)

Dr. Gurjit S. Kaeley

Rheumatology
University Of Florida Jacksonville Physicians, Inc.
653 W 8th St, 
Jacksonville, FL 
Accepting New Patients
30 Years of Experience
Experienced in Juvenile Idiopathic Arthritis (JIA)
University Of Florida Jacksonville Physicians, Inc.
653 W 8th St, 
Jacksonville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gurjit Kaeley is a Rheumatologist in Jacksonville, Florida. Dr. Kaeley has been practicing medicine for over 30 years and is rated as an Experienced provider by MediFind in the treatment of Juvenile Idiopathic Arthritis (JIA). His top areas of expertise are Synovitis, Arthritis, Rheumatoid Arthritis (RA), Psoriatic Arthritis, and Synovectomy. Dr. Kaeley is currently accepting new patients.

His clinical research consists of co-authoring 93 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Juvenile Idiopathic Arthritis (JIA).

Specialties
Rheumatology
Licenses
Internal Medicine in WA
Hospital Affiliations
Shands Jacksonville
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northwell Health
  • INSURANCE PLAN
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
653 W 8th St, Jacksonville, FL 32209

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 4 Less Clinical Trials

93 Total Publications

Toward Increasing Precision in the Early Diagnosis of Psoriatic Arthritis.
Toward Increasing Precision in the Early Diagnosis of Psoriatic Arthritis.
Journal: The Journal of rheumatology
Published: August 05, 2025
Similar Doctors
Experienced in Juvenile Idiopathic Arthritis (JIA)
Dr. Karishma P. Ramsubeik
Rheumatology
Experienced in Juvenile Idiopathic Arthritis (JIA)
Dr. Karishma P. Ramsubeik
Rheumatology

Baptist Primary Care Inc

13241 Bartram Park Blvd, Unit 2105, 
Jacksonville, FL 
 (16.7 miles away)
904-292-4111
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Karishma Ramsubeik is a Rheumatologist in Jacksonville, Florida. Dr. Ramsubeik is rated as an Advanced provider by MediFind in the treatment of Juvenile Idiopathic Arthritis (JIA). Her top areas of expertise are MASS Phenotype, Mixed Connective Tissue Disease, Rheumatoid Arthritis (RA), Gout, and Tissue Biopsy. Dr. Ramsubeik is currently accepting new patients.

Experienced in Juvenile Idiopathic Arthritis (JIA)
Dr. Meera R. Oza
Rheumatology
Experienced in Juvenile Idiopathic Arthritis (JIA)
Dr. Meera R. Oza
Rheumatology
2100 Kingsley Ave, 
Orange Park, FL 
 (13.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Meera Oza is a Rheumatologist in Orange Park, Florida. Dr. Oza is rated as a Distinguished provider by MediFind in the treatment of Juvenile Idiopathic Arthritis (JIA). Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Synovitis. Dr. Oza is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kaeley's expertise for a condition
ConditionClose
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile